Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankaj R Patel

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 1, 2008
Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligandsSaurin Raval, Preeti Raval, Debdutta Bandyopadhyay, et al.
Bioorganic & Medicinal Chemistry|June 23, 2007
Synthesis of 3,8,9-trisubstituted-1,7,9-triaza-fluorene-6-carboxylic acid derivatives as a new class of insulin secretagoguesRajesh H Bahekar, Mukul R Jain, Pradip A Jadav, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2007
Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinonesBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2019
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar ratsPoonam Giri, Prashant Delvadia, Meera K Ladani, et al.
British Journal of Pharmacology|April 29, 2017
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitusMukul R Jain, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Bioanalysis|May 11, 2017
A sensitive assay for ZYAN1 in human whole blood and urine utilizing positive LC-MS/MS electrospray ionizationHarilal Patel, Krunal Soni, Rucha Trivedi, et al.
Bioorganic & Medicinal Chemistry|August 29, 2007
Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridinesRajesh H Bahekar, Mukul R Jain, Pradip A Jadav, et al.
European Journal of Medicinal Chemistry|July 6, 2007
Synthesis and in vitro antibacterial activities of novel oxazolidinonesBrijesh Kumar Srivastava, Mukul R Jain, Manish Solanki, et al.
Journal of Diabetes|October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitorMukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|July 1, 2008
Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligandsSaurin Raval, Preeti Raval, Debdutta Bandyopadhyay, et al.
Bioorganic & Medicinal Chemistry|June 23, 2007
Synthesis of 3,8,9-trisubstituted-1,7,9-triaza-fluorene-6-carboxylic acid derivatives as a new class of insulin secretagoguesRajesh H Bahekar, Mukul R Jain, Pradip A Jadav, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2007
Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinonesBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2019
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar ratsPoonam Giri, Prashant Delvadia, Meera K Ladani, et al.
British Journal of Pharmacology|April 29, 2017
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitusMukul R Jain, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Bioanalysis|May 11, 2017
A sensitive assay for ZYAN1 in human whole blood and urine utilizing positive LC-MS/MS electrospray ionizationHarilal Patel, Krunal Soni, Rucha Trivedi, et al.
Bioorganic & Medicinal Chemistry|August 29, 2007
Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridinesRajesh H Bahekar, Mukul R Jain, Pradip A Jadav, et al.
European Journal of Medicinal Chemistry|July 6, 2007
Synthesis and in vitro antibacterial activities of novel oxazolidinonesBrijesh Kumar Srivastava, Mukul R Jain, Manish Solanki, et al.
Journal of Diabetes|October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitorMukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Pageof 4